Gastric Cancer Market Research and Forecast

1
Gastric Cancer Market Research and Forecast
Gastric cancer testing market, size, share,
market intelligence, company profiles, market
trends, strategy, analysis, forecast 2017-2022
https//www.omrglobal.com/industry-reports/stomach
-cancer-market/
2
TABLE OF CONTENTS

• REPORT SUMMARY
• 1.1.         RESEARCH METHODS AND TOOLS
• 1.2.         MARKET BREAKDOWN
• 1.2.1.      BY SEGMENTS
• 1.2.2.      BY GEOGRAPHY
• 1.2.3.      BY STAKEHOLDERS
• 1.2.4.      EXCEPTIONS

3
TABLE OF CONTENTS

• MARKET OVERVIEW AND INSIGHTS
• 2.1.         DEFINITION
• 2.2.         ANALYST INSIGHTS CURRENT MARKET
  TRENDS
• 2.2.1.      KEY FINDINGS
• 2.2.2.      RECOMMENDATION
• 2.2.3.      CONCLUSION

4
TABLE OF CONTENTS

• MARKET DETERMINANT
• 3.1.         MOTIVATORS
• 3.1.1.      RISING GASTRIC CANCER CASES GLOBALLY
• 3.1.2.      GROWING ADOPTION OF NOVEL THERAPIES
  AND
• TREATMENT FOR
  METASTATIC STOMACH CANCER
• 3.2.         RESTRAINT
• 3.3.         OPPORTUNITY   

5
TABLE OF CONTENTS

• MARKET SEGMENTATION
• 4.1.         GASTRIC CANCER TESTING MARKET
  RESEARCH
• AND ANALYSIS BY TESTING TYPE
• 4.1.1.      CHEST X-RAY
• 4.1.2.      COMPUTED TOMOGRAPHY (CT OR CAT) SCAN
•  4.2.         GASTRIC CANCER TESTING MARKET
  RESEARCH
• AND ANALYSIS BY DRUG CLASS
• 4.2.1.      DOCETAXEL

6
TABLE OF CONTENTS

• 4.3.         GASTRIC CANCER TESTING MARKET
  RESEARCH
• AND ANALYSIS, BY TREATMENT TYPE
• 4.3.1.      ADJUVANT CHEMOTHERAPY
• 4.3.2.      CHEMO THERAPY
• 4.4.         GASTRIC CANCER TESTING MARKET
  RESEARCH AND
• ANALYSIS, BY END USER
• 4.4.1.      HOSPITALS
• 4.4.2.      CLINICS

7
STOMACH CANCER MARKET INSIGHTS

• The Stomach cancer market is expected to grow at
  a modest CAGR of 5.8 during 2017-2022. Growing
  elderly population, technological advancement and
  rising incidence and prevalence rate of gastric
  cancer are boosting the stomach cancer market
  across the globe. Gastric cancer leads to
  uncontrolled progress of malignant cells that
  originate in stomach tissue. The main cause for
  the developing stomach cancer is still not known
  exactly, but bacterium Helicobacter Pylori is one
  of the key cause and also Smoking ulcer are
  some factors leading to stomach cancer.

8
STOMACH CANCER MARKET INSIGHTS

• Other factor included such as age, diet, and
  stomach disease can affect the risk of developing
  stomach cancer. Approx. 800,000 cancer related
  death are causes by gastric cancer every year, as
  per World Health Organization.
• According to National Institute of Cancer, United
  States the stomach cancer is common in both men
  and women. Age, diet and stomach disease,
  including infection with Helicobacter pylori can
  affect the risk of developing stomach cancer. The
  number of new cases of stomach cancer was 7.3 per
  100,000 men and women per year based on 2010-2014
  cases.

9
STOMACH CANCER MARKET INSIGHTS

• The Gastric cancer testing market can be
  segmented majorly into three parts on the basis
  of testing type, drug class, treatment type and
  end users. Testing type, the industry further
  segmented into chest x-ray, computed tomography
  (CT or CAT) scan, helicobacter pylori, imaging
  tests, laparoscopy, magnetic resonance imaging
  (MRI) scan, positron emission tomography (PET)
  scan and upper gastrointestinal (GI) series. And
  on the basic of drug class market can be
  segmented into Docetaxel, Doxorubicin
  Hydrochloride, Fluorouracil, Imatinib, Mitomycin
  C, Sunitinib And Trastuzumab.

10
STOMACH CANCER MARKET INSIGHTS

• And lastly treatment type can be segmented into
  adjuvant chemotherapy, chemo therapy, radiation
  therapy, surgery and targeted drugs therapy. The
  stomach cancer market is rising rapidly as
  increasing incidence of adenocarcinoma,
  gastrointestinal stromal tumors and lymphoma
  across the globe. Most significant drivers are
  for the stomach cancer market include, increasing
  number of cancer treatment centers, treatment
  advancements, combination therapies, large number
  of regulatory approvals for metastatic gastric
  cancer and low dose radiation technology based
  devices.

11
Geographical Insights

• The highest incidence and prevalence of stomach
  cancer has been predicted to be in Asia, Latin
  America and the Caribbean and the lowest
  incidence in North America and Africa. More than
  60 of the global gastric cancer cases are from
  emerging economies such as South Korea, China
  Japan, Mongolia and India. Growing disposable
  income, awareness and healthcare spending will
  further drive the gastric cancer testing market
  in APAC region. China and Japan having the
  largest drug market share in terms large patient
  base and rise in treatment seeking population in
  these regions.

12
Geographical Insights

• According to the statistics World Cancer Research
  Fund International of the year 2012, Japan having
  the largest market share of approximately 24.7
  in the global stomach cancer treatment market due
  to high consumption of salty and pickled foods.
  Not only just Japan (31.1 new cases /100,000),
  other countries such as South Korea (41.4), China
  (29.9), and Mongolia (34) have high incidence
  rates of stomach cancer. The gastric cancer drug
  market in North America and Europe rising
  strongly in uptake of gastric cancer drugs
  specifically Herceptin, Erbitux and Afitnitor
  also emphasizes the growth of these drugs.

13
Competitive Insights

• The key players in the global market includes,
  Abbott, Biogen Idec, Bristol Myers Squibb,
  Danaher corporation, Oncolytics Biotech Inc., Eli
  Lilly and company, F. Hoffmann-La Roche Ltd.,
  GlaxoSmithKline plc, Merck KGaA, Novartis
  International AG and Otsuka Holdings Co. Ltd. Top
  companies are focusing on delivering
  differentiated treatments by adopting new method
  of treatments through launched products and
  upcoming targeted therapies during the forecast
  period.

14
Market Segmentation

• Gastric cancer testing market is segmented on the
  basis of testing type, drug class, and treatment
  type. The major segment in gastric cancer testing
  market testing type, drug class, and treatment
  type includes chest x-ray, computed tomography
  (CT or CAT) scan, helicobacter pylori, imaging
  tests, docetaxel, doxorubicin hydrochloride,
  fluorouracil, imatinib, chemo therapy, radiation
  therapy, surgery and targeted drugs therapy.
  Stomach cancer market are, combination therapies,
  increasing number of cancer treatment centers,
  treatment advancements, large number of
  regulatory approvals for metastatic gastric
  cancer.

15
Market Segmentation

• Gastric cancer testing market research and
  analysis, by testing type
• Gastric cancer testing market research and
  analysis, by drug class
• Gastric cancer testing market research and
  analysis, by treatment type
• Gastric cancer testing market research and
  analysis, by end user type

16
OMR REPORT COVERS

• Comprehensive research methodology of gastric
  cancer testing market.
• This report also includes detailed and extensive
  market overview with key analyst insights.
• Exhaustive analysis of macro and micro factors
  influencing the market guided by key
  recommendations.
• Analysis of regional regulations and other
  government policies impacting the gastric cancer
  testing market.

17
OMR REPORT COVERS

• Insights about market determinants which are
  stimulating the gastric cancer testing market.
• Detailed and extensive market segments with
  regional distribution of forecasted revenues.
• Extensive profiles and recent developments of
  market players.

18
Contact US
CORPORATE OFFICE

Orion Market Research Pvt. Ltd. (OMR Global)116,
Shagun Arcade, Vijay Nagar Square, Indore, Madhya
PradeshIndia- 452010
1-646-755-7667 (Global)
91-7803040404 (India)
  info_at_omrglobal.com, Support_at_omrglobal.com
www.omrglobal.com
We Analyze Future Simply
https//www.omrglobal.com/industry-reports/stomach
-cancer-market/